Basis of Presentation and Significant Accounting Policies (Details Narrative) - Chemomab Therapeutics Ltd [Member] $ in Thousands |
6 Months Ended | 12 Months Ended | ||
|---|---|---|---|---|
Jun. 30, 2026 |
Dec. 31, 2025
USD ($)
Segment
|
Dec. 31, 2024
USD ($)
|
Dec. 31, 2023
USD ($)
|
|
| Impairment of long lived assets | $ 0 | $ 0 | $ 0 | |
| Percentage of monthly deposits rate | 8.33% | |||
| Severance costs | $ 42 | $ 50 | $ 86 | |
| Incremental borrowing rate | 9.00% | 9.00% | ||
| Number of reportable segment | 1 | 1 | ||
| Minimum [Member] | ||||
| Percentage of short term deposits | 4.15% | 4.24% | ||
| Maximum [Member] | ||||
| Percentage of short term deposits | 4.26% | 5.75% | ||